China-invented vaccines against vaccine-preventable diseases for Belt & Road countries

Abstract

Vaccine is a principal and highly cost-effective medical method on controlling infectious diseases and improving population health. Various vaccines are eagerly needed in the low-income countries along the Belt & Road. With the good quality to reach WHO prequalification standard, and the abundant capacity to fulfill the demand from market abroad, upon the platform of China-proposed “the Belt & Road Initiative” the vaccines manufactured in China are exporting to countries worldwide. The independent innovative vaccines’ R&D system, which fruited a series of innovative infectious diseases vaccines (EV71 vaccine, sIPV, HEV, Ebola vaccine, etc.) to be launched in Chinese market, indicates that China has developed rapidly from “a great vaccine-production country” to “a powerful vaccine-innovation country”. The implementation of National Innovation-driven Development Strategy would further push forward the development and internationalization process of Chinese innovative vaccines. Therefore, the China-invented vaccines will make an important role in the prevention and control of infectious disease in various countries and become one of the most powerful weapons in fighting the global epidemic event in the future.

Keywords

• the Belt and Road Initiative
• innovative vaccines
• infectious disease
• vaccine export
• WHO prequalification standard